Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
. The review is devoted to the most important aspects of primary mixed dyslipidemia treatment in patients at high risk with concomitant metabolic comorbidities. Evidences for novel modern approaches regarding primary prevention of cardiovascular events among dyslipidemic patients are considered. Th...
Saved in:
| Main Authors: | A. E. Berezin, T. V. Sheychenko, T. A. Berezina, N. V. Vishnevaya, N. V. Kovalenko, Z. I. Kulik, I. А. Мoiseenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dnipro State Medical University
2015-06-01
|
| Series: | Medičnì Perspektivi |
| Subjects: | |
| Online Access: | http://journals.uran.ua/index.php/2307-0404/article/view/45652 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
by: Berezin A.E., et al.
Published: (2015-06-01) -
Indicators of carbohydrate metabolism in a patient with dyslipidemia and impaired fasting glycemia receiving pitavastatin: a case report
by: A. A. Nekrasov, et al.
Published: (2023-01-01) -
Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01) -
New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
by: V. V. Syvolap, et al.
Published: (2014-04-01) -
Endothelial protective effect of pitavastatin
by: A. S. Berns, et al.
Published: (2023-10-01)